In patients with MS, there were more CD4+ T cells that produced IL-17A, GM-CSF, and IFNγ than those from healthy controls, and the percentage of STAT3+ cells in CD4+ and CD8+ T cells from patients with MS was increased (169). Here, IL17A is linked to myeloid sarcoma.